NCT02489903 2025-03-17RRx-001 in Lung Cancer, Ovarian Cancer and Neuroendocrine Tumors Prior to Re-administration of Platinum Based Doublet Regimens (QUADRUPLE THREAT)EpicentRx, Inc.Phase 2 Completed139 enrolled 14 charts
NCT00003657 2017-01-20High-dose ICE With AmifostineDana-Farber Cancer InstitutePhase 2 Completed24 enrolled
NCT00003269 2011-01-10Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid TumorsScripps HealthPhase 2 Completed20 enrolled